Trial of pig livers as dialysis-like treatment for liver failure approved by FDA

US Food and Drug Administration has approved a first-of-its kind clinical trial wherein researchers will test whether livers from a gene-edited pig could treat people with sudden liver failure by temporarily filtering their blood so their own organ can rest. Researchers won't transplant the liver but will attach it externally. A device will pump participants' blood through the pig liver.